Dr Marcellina Oluwatomi Coker
Honourable Commissioner For Health,
Ogun State
Dr Marcellina Oluwatomi Coker is an administrator, Consultant Obstetrician and Gynaecologist with over twenty years of experience and a Public Health Practitioner.
Her professional experience is underpinned by twenty-eight years of experience in the discipline of Obstetrics and Gynaecology (O&G) in the world-renowned British National Health Service.
A graduate of University of Ibadan, Fellow of the Royal College of Obstetricians and Gynaecologist and an alumnus of the Harvard Kennedy School. Held the role of Clinical Director within the NHS Trust UK for 5 years where she transformed a Maternity Services identified by the hospital regulator Care Quality Commission UK as failing and moved it two grades up in quality of care delivered to ‘GOOD’ within six months which is a feat that had never been attained in the history of National Health Service UK.
Currently, she is the Commissioner for Health Ogun State since January 2020. Through her leadership as the Incident Commanding Officer, Ogun State deployed an effective Covid-19 response to the 1st reported case of Covid-19 in Sub-Saharan Africa which culminated in being the recipient of “The Best Southwestern Nigeria State in deployment of the Covid-19 vaccine”.
Dr Coker has implemented various transformative projects to revitalize the primary health system through innovation and leveraging on technology to deliver quality Maternal and Child healthcare across the state with a focus on the rural and hard to reach areas. This earned her the recognition as “One hundred Most Influential People of Black Descent in Healthcare” and recipient of “The PHC Leadership Challenge Award” in Southwest Nigeria conferred by Bill and Melinda Gates and UNICEF.
Dr. Coker is passionate about Maternal and Child Health, a motivational speaker on Women’s Health, and an advocate for the underprivileged. A lover of the outdoor particularly golfing and mountain climbing.
She is poised to drive the Global Public Health agenda on improving women’s health indices both nationally and internationally by deploying disruptive strategies that rely on clinical innovations and technology.
